Takeda Oncology is dedicated to developing and delivering novel medicines to cancer patients worldwide through our science, innovation, and passion. With our recent acquisition of ARIAD Pharmaceuticals, a leader in targeted oncology therapies, we are strengthening and diversifying our therapeutic areas. Our legacy includes therapies for hematologic cancers and solid tumors, including lung cancer. We aspire to cure cancer.